Earnings Scheduled For August 18, 2022
Companies Reporting Before The Bell
• Calliditas Therapeutics (NASDAQ:CALT) is expected to report quarterly loss at $1.00 per share on revenue of $7.50 million.
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.
Nasdaq Jumps Over 100 Points; U.S. Jobless Claims Rise To This Level
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Thursday.
Stocks That Hit 52-Week Lows On Thursday
During Thursday's trading, 50 companies set new 52-week lows.
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.
LumiraDx Announces Proposed Public Offering Of 40M Shares
LumiraDx Limited (NASDAQ:LMDX), a next-generation point of care (POC) diagnostics company, today announced that it has commenced an underwritten public offering of 40,000,000 common shares. All of the shares in the
